Johnson & Johnson (JNJ) Releases Earnings Results, Beats Expectations By $0.02 EPS

Johnson & Johnson (JNJ) announced its most recent quarterly financial results on Tuesday, Oct-18-2016. JNJ said it had a profit of $1.68 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.02. Analysts had a consensus of $1.66. The company posted revenue of $17820.00 million in the period, compared to analysts expectations of $17744.90 million. JNJ’s revenue was up 4.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.49 EPS.

Johnson & Johnson closed down -0.7 points or -0.59% at $117.56 with 56,40,519 shares getting traded on Friday. Post opening the session at $118.5, the shares hit an intraday low of $117.56 and an intraday high of $118.8 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

In a different news, on Jul 28, 2016, Dominic J Caruso (Exec VP, Finance; CFO) sold 41,146 shares at $125.01 per share price. According to the SEC, on Jul 25, 2016, Ronald A Kapusta (Controller, CAO) sold 2,935 shares at $125.01 per share price. On Jun 9, 2016, Gary J Pruden (Exec VP, WW Chair, Med Devices) sold 9,735 shares at $116.03 per share price, according to the Form-4 filing with the securities and exchange commission.

Johnson & Johnson is a holding company. The Company is engaged in the research and development manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Company’s primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer Pharmaceutical and Medical Devices. The Company’s subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Company’s research facilities are located in the United States Belgium Brazil Canada China France Germany India Israel Japan the Netherlands Singapore Switzerland and the United Kingdom.

Johnson & Johnson

Leave a Reply

Johnson & Johnson - Is it time to Sell?

Top Brokerage Firms are advising their investors on Johnson & Johnson. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.